< img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=252315582667293&ev=PageView&noscript=1" />
Transforming Cardiac Care: EDAN's Journey in ECG Innovation
Release time:2020-04-20

In the realm of medical diagnostics, electrocardiography (ECG) has remained a cornerstone for over a century. Since Einthoven recorded the world’s first ECG in 1901, the technology has evolved dramatically, playing a vital role in detecting cardiovascular conditions. China’s EDAN has risen from humble beginnings to become a global leader in ECG innovation, blending technical prowess with a commitment to improving global healthcare.


From Humble Beginnings to Pioneering Achievements

China’s ECG journey began in 1954, with Shanghai Xinkang Industrial Society producing the country’s first electrocardiograph. However, reliance on imports persisted until the late 20th century. Recognizing this gap, EDAN entered the ECG field in 2000, establishing its first research team.

Starting from scratch, EDAN launched its first single-channel and three-channel ECG machines in 2004. These devices, lauded for their ease of use and reliability, secured EDAN’s foothold in the market. By 2006, the company’s SE-3 3-channel ECG machine propelled its export volume to the top among domestic competitors. 

图片1.png

SE-1/SE-100


A landmark achievement came in 2008 with the SE-12 Express, a 12-channel digital ECG machine capable of collecting both static and dynamic ECGs. This innovation earned EDAN accolades, including recognition as a “Guangdong Province Independent Innovation Product.” 

图片2.png

SE-12


Advancing Healthcare with Breakthrough Technologies

As cardiovascular diseases became a leading global health concern, EDAN accelerated innovation. In 2015, the company introduced the SE-18, China’s first true 18-lead ECG machine, offering unparalleled precision for diagnosing myocardial infarction. Its groundbreaking 16,000-point sampling rate ensured even the faintest pacing signals could be captured. 

图片3.png

SE-18


In 2021, EDAN unveiled the SE-1202, a high-end flagship ECG machine with an industry-leading sampling rate of 80,000 Hz. This innovation resolved long-standing challenges in pediatric and pacing ECG diagnostics, filling critical gaps in clinical care. 

图片4.png

SE-1202


In response to the growing need for integrated solutions, EDAN launched the SA-20, a dual-function dynamic ECG and blood pressure recorder. This device synchronized data to enhance diagnostic accuracy for cardiovascular diseases.


Building a Smart Future

EDAN has also embraced intelligent technologies and digital integration. The company’s Smart ECG Net system, launched in 2010, marked its evolution from hardware provider to integrated solution specialist. By 2024, EDAN’s smart health solutions had been implemented across 31 Chinese provinces, serving over 10,000 hospitals and facilitating more than 20 million remote ECG diagnoses.

In the same year, EDAN debuted the ST-1515 exercise ECG stress test system, addressing the challenge of early detection for latent coronary heart disease.


A Global Leader

EDAN’s commitment to innovation has propelled its products to over 170 countries, including the United States, Germany, and Japan. Trusted by premier institutions such as Peking Union Medical College Hospital and West China Hospital, EDAN’s ECG machines are synonymous with reliability and precision.

Since 2006, EDAN has been the largest domestic brand in China in terms of export value, holding this position for over 15 consecutive years, according to customs statistics. Domestically, EDAN’s market share ranks first in the ECG field, solidifying its position as one of China’s leading ECG brands.

Although China's ECG industry started later than its counterparts in Europe and the United States, decades of innovation have enabled it to overcome technical barriers, achieve domestic substitution, and gain a growing foothold in the global market. EDAN exemplifies this transformation, proving that Chinese technology can compete at the highest levels on the international stage.


Shaping the Future of ECG

With over 100 patents and a commitment to innovation, EDAN continues to set benchmarks in the ECG field. Its dedication to addressing clinical challenges has redefined the role of ECG technology in modern medicine.

Looking ahead, the company is committed to combining AI, advanced algorithms, and smart integration to make healthcare more efficient and equitable. From remote diagnostics to high-precision devices, EDAN is shaping a future where every patient has access to world-class cardiovascular care.

In the words of EDAN: “Innovation with purpose is what truly matters. Every heartbeat tells a story, and our mission is to ensure that story leads to better health outcomes—wherever it is told.”